Clinical Trials

6 enrolled

Solid Tumor, Adult

NCT05223608 2026-03-30

ImmuCCo

Phase NA Recruiting

651 enrolled

Solid Tumor, Adult

NCT05763004 2026-03-27

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors

140 enrolled

Solid Tumor, Adult

NCT06554795 2026-03-27

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

360 enrolled

Solid Tumor, Adult

NCT04221204 2026-03-25

A Monotherapy in Subjects With Advanced Solid Tumors

42 enrolled

Solid Tumor, Adult

NCT06265688 2026-03-25

First In Human Study of CX-2051 in Advanced Solid Tumors

160 enrolled

Solid Tumor, Adult

NCT06977737 2026-03-25

ATTEST

72 enrolled

Solid Tumor, Adult

NCT06462794 2026-03-24

First In Human Study of CX-801 in Advanced Solid Tumors

121 enrolled

Solid Tumor, Adult

NCT05689853 2026-03-18

Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors

87 enrolled

Solid Tumor, Adult

NCT06391918 2026-03-13

Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

Phase 1 Terminated

37 enrolled

Solid Tumor, Adult

NCT04928508 2026-03-05

Okgyn1

50 enrolled

Phase NA Active not recruiting

Solid Tumor, Adult

NCT07137195 2026-02-27

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)

47 enrolled

Solid Tumor, Adult

NCT05381909 2026-02-20

A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors

Phase 1 Terminated

157 enrolled

Solid Tumor, Adult

NCT06507306 2026-02-06

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

100 enrolled

Phase NA Not yet recruiting

Solid Tumor, Adult

NCT06772090 2026-02-03

Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies

40 enrolled

Solid Tumor, Adult

NCT06397963 2026-01-26

Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours

Phase NA Recruiting

18 enrolled

Solid Tumor, Adult

NCT04504942 2026-01-23

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

Phase 2 Completed

16 enrolled 16 charts

Phase NA Active not recruiting

Solid Tumor, Adult

NCT07153094 2026-01-16

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Shenzhen)

47 enrolled

Phase 1 Not yet recruiting

Solid Tumor, Adult

NCT07294872 2026-01-16

A Study of TIL in Advanced Solid Tumors (CZ)

30 enrolled

Phase 1/2 Active not recruiting

Solid Tumor, Adult

NCT04725474 2026-01-12

GDFATHER

263 enrolled

Solid Tumor, Adult

NCT07159828 2026-01-09

A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

52 enrolled

Solid Tumor, Adult

NCT06265727 2026-01-08

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

348 enrolled

Solid Tumor, Adult

NCT03905148 2026-01-07

Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors

91 enrolled

Phase NA Active not recruiting

Solid Tumor, Adult

NCT07152353 2026-01-07

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Sichuan)

47 enrolled

Solid Tumor, Adult

NCT05307874 2025-12-24

EVICTION-2

Phase 1/2 Completed

56 enrolled

Solid Tumor, Adult

NCT06383884 2025-12-15

Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion

Phase 2 Recruiting

30 enrolled

Solid Tumor, Adult

NCT05582850 2025-08-28

EPRAD

29 enrolled

Solid Tumor, Adult

NCT06088004 2025-08-22

Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

218 enrolled

Solid Tumor, Adult

NCT02220556 2025-08-08

CTC-CEC-ADN

Phase NA Completed

360 enrolled

Solid Tumor, Adult

NCT03410121 2025-08-05

PACPAC-EPOC

Phase NA Completed

361 enrolled

Solid Tumor, Adult

NCT03772561 2025-07-22

MEDIPAC

40 enrolled

Solid Tumor, Adult

NCT03990233 2025-06-26

A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours

100 enrolled

Solid Tumor, Adult

NCT05435339 2025-04-22

A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy

Phase 1/2 Terminated

31 enrolled 29 charts

Solid Tumor, Adult

NCT06462716 2025-04-13

A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors

36 enrolled

Solid Tumor, Adult

NCT05620472 2025-04-09

Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1

10 enrolled

Solid Tumor, Adult

NCT06895733 2025-03-26

Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)

65 enrolled

Phase 1/2 Active not recruiting

Solid Tumor, Adult

NCT04585035 2025-03-18

Study to Evaluate D-1553 in Subjects With Solid Tumors

180 enrolled

Other solid neoplasmThoracic

Solid Tumor, Adult

NCT04597541 2025-03-10

A Study of AK112 for Advanced Solid Tumors

Phase 1/2 Completed

59 enrolled

Solid Tumor, Adult

NCT04105335 2025-03-06

TIMEPOINT

50 enrolled

Solid Tumor, Adult

NCT06032845 2025-02-27

CASTLE-11

Phase 2 Recruiting

25 enrolled

Solid Tumor, Adult

NCT05559541 2025-02-19

Study of AK119 Combined With AK104 in Patients With Advanced Solid Tumors

Phase 1/2 Terminated

33 enrolled

Solid Tumor, Adult

NCT04643574 2025-02-14

NeoTIL in Advanced Solid Tumors

42 enrolled

Solid Tumor, Adult

NCT05601219 2025-01-28

A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors

Phase 1 Terminated

46 enrolled

Solid Tumor, Adult

NCT06524804 2024-12-18

A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined with Radiotherapy in Patients with Malignant Solid Tumors

Phase 1/2 Terminated

60 enrolled

Solid Tumor, Adult

NCT04020185 2024-12-11

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Phase 1/2 Completed

40 enrolled 16 charts

Solid Tumor, Adult

NCT06026254 2024-11-18

A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial

2 enrolled

Solid Tumor, Adult

NCT06003621 2024-11-15

MoST-TAP

Phase 2 Recruiting

96 enrolled

Solid Tumor, Adult

NCT06622486 2024-11-07

First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors

50 enrolled

Solid Tumor, Adult

NCT03516123 2024-09-19

A Study of CS3006 in Subjects with Locally Advanced or Metastatic Solid Tumors

18 enrolled